Clinical trial
To Study the Effectiveness of Ivermectin With Standard of Care Treatment Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study
NCT04373824 is registered in ClinicalTrials.gov with Max Healthcare Insititute Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- To Study the Effectiveness of Ivermectin With Standard of Care Treatment Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study
- Lead sponsor
- Max Healthcare Insititute Limited
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 25, 2020
- Completion date
- July 25, 2020
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid